To investigate a novel intronic variant in the COL4A5 gene and assess its pathogenic implications in a Chinese family affected by X-linked Alport syndrome (XLAS), highlighting its significance in the context of existing research.
Key Findings:
A novel splice variant (c.1587+4A>G) was identified in intron 23 of COL4A5, with potential clinical implications for diagnosis and treatment.
The variant co-segregated with the disease phenotype in affected family members.
Functional assays confirmed that the variant leads to abnormal mRNA splicing and exon 23 skipping, resulting in a frameshift and premature termination codon.
Interpretation:
The discovery of the c.1587+4A>G variant expands the mutational spectrum of COL4A5 in XLAS and highlights the importance of transcript analysis for understanding intronic variants, potentially impacting clinical practice.
Limitations:
The study is limited to a single family, which may restrict the generalizability of the findings and their applicability to broader populations.
Further studies are needed to assess the prevalence and impact of this variant in broader populations.
Conclusion:
This research underscores the significance of evaluating intronic variants in the COL4A5 gene and provides functional evidence for the pathogenicity of the identified variant, emphasizing the need for further research on intronic variants.
